An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum
Authors
Keywords
-
Journal
Alzheimers & Dementia
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-12-19
DOI
10.1002/alz.12204
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biomarkers for Alzheimer’s disease—preparing for a new era of disease-modifying therapies
- (2020) Henrik Zetterberg et al. MOLECULAR PSYCHIATRY
- Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum
- (2020) Marta Milà‐Alomà et al. Alzheimers & Dementia
- Elecsys® Total-Tau and Phospho-Tau (181P) CSF assays: Analytical performance of the novel, fully automated immunoassays for quantification of tau proteins in human cerebrospinal fluid
- (2019) Valeria Lifke et al. CLINICAL BIOCHEMISTRY
- CSF and blood biomarkers for Parkinson's disease
- (2019) Lucilla Parnetti et al. LANCET NEUROLOGY
- Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age
- (2019) Tobey J Betthauser et al. BRAIN
- Predicting clinical decline and conversion to Alzheimer’s disease or dementia using novel Elecsys Aβ(1–42), pTau and tTau CSF immunoassays
- (2019) Kaj Blennow et al. Scientific Reports
- Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging
- (2018) Suzanne E. Schindler et al. Alzheimers & Dementia
- The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review
- (2018) Oskar Hansson et al. Alzheimers & Dementia
- CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
- (2018) Oskar Hansson et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- The Past and the Future of Alzheimer’s Disease Fluid Biomarkers
- (2018) Kaj Blennow et al. JOURNAL OF ALZHEIMERS DISEASE
- Neurodegeneration, synaptic dysfunction, and gliosis are phenotypic of Alzheimer dementia
- (2018) Andrew P. Merluzzi et al. NEUROLOGY
- Biomarkers for Alzheimer's disease: current status and prospects for the future
- (2018) K. Blennow et al. JOURNAL OF INTERNAL MEDICINE
- CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
- (2018) Shorena Janelidze et al. NEUROLOGY
- Current state of Alzheimer’s fluid biomarkers
- (2018) José Luis Molinuevo et al. ACTA NEUROPATHOLOGICA
- Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons
- (2017) Michael C. Donohue et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Peripheral inflammatory markers in Alzheimer’s disease: a systematic review and meta-analysis of 175 studies
- (2017) Ka Sing P Lai et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports
- (2017) Pashtun Shahim et al. NEUROLOGY
- Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
- (2017) Piotr Lewczuk et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Results From the NACC Uniform Data Set Neuropsychological Battery Crosswalk Study
- (2016) Sarah E. Monsell et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1–42) in human cerebrospinal fluid
- (2016) Tobias Bittner et al. Alzheimers & Dementia
- Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
- (2016) Sebastian Palmqvist et al. BRAIN
- sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
- (2016) Marc Suárez‐Calvet et al. EMBO Molecular Medicine
- Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
- (2016) Mehtap Bacioglu et al. NEURON
- Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression
- (2016) Henrik Zetterberg et al. JAMA Neurology
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- Amyloid biomarkers in Alzheimer's disease
- (2015) Kaj Blennow et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The Preclinical Alzheimer Cognitive Composite
- (2014) Michael C. Donohue et al. JAMA Neurology
- Dissecting phenotypic traits linked to human resilience to Alzheimer’s pathology
- (2013) Beatriz G. Perez-Nievas et al. BRAIN
- Amyloid burden and neural function in people at risk for Alzheimer's Disease
- (2013) Sterling C. Johnson et al. NEUROBIOLOGY OF AGING
- Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
- (2012) Peder Buchhave ARCHIVES OF GENERAL PSYCHIATRY
- Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010
- (2012) Thomas G. Beach et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study
- (2012) Adam S Fleisher et al. LANCET NEUROLOGY
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now